Santa Cruz Biotechnology
Skp2 p45 siRNA
sc-36499
Info:Supplier Page View Product Specs View Product
The aim was to knock down SKP2 in human oral keratinocytes and examine if knocking down SKP2 wound impairs cell proliferation. By following the protocol, SKP2 siRNA did its job.
siRNA transfection
Oral keratinocytes
Follow the protocol.
SKP2 siRNA (20nM in a 12-well plate) was transfected into oral keratinocytes by following the protocol. The transfection significantly inhibited SKP2 mRNA expression.
N/A
It was easy to use and worked.
None
It works well.